Keros Therapeutics, Inc. (KROS) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 757.82M |
| Enterprise Value | 487.29M |
| P/E Ratio | -3.72 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 5.03 |
| Price/Book Ratio | 0.74 |
| Enterprise/Revenue | -0.96 |
| Enterprise/EBITDA | 0.64 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | -1.51 |
| Operating Margin | -1.8 |
| Return On Assets | -0.2 |
| Return On Equity | -0.22 |
| Revenue | 244.06M |
| Revenue/Share | 2.05 |
| Gross Profit | 242.55M |
| EBITDA | 93.41M |
| Net Income | 87.01M |
| Diluted EPS | 2.3 |
| Total Cash | 259.46M |
| Total Cash/Share | 13.05 |
| Total Debt | 15.11M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 18.14 |
| Book Value Per Share | 14.03 |
| 52-Week Change | -40.18 |
| 52-Week High | 22.55 |
| 52-Week Low | 8.98 |
| Moving Average 50 Days | 11.08 |
| Moving Average 200 Days | 11.7 |
| Average Volume | 181,007 |
| Shares Outstanding | 19.62M |
| % Held by Institutions | 94.51 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |